LALINDEN ADVISORS LP

Institutional investor · Portfolio as of Q1 2025

SEC EDGAR SourceSEC Filings

Top Holdings307 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
267.9M$545.4M3.7%———
New
87
380.8M$490.5M3.3%———
Increased
59
393.1M$381.1M2.6%———
New
80
338.9M$314M2.1%———
New
80
286.5M$303.6M2.1%———
Increased
86
??LI AUTO INCDelisted
Bond
254.4M$300.1M2.0%———
Increased
57
??CONFLUENT INCDelisted
Bond
316.9M$293M2.0%———
Decreased
0
??INSMED INCDelisted
Bond
117.4M$278.6M1.9%———
Increased
51
264.9M$274.6M1.9%———
Increased
53
77.5M$245.5M1.7%———
Decreased
0
92.8M$238M1.6%———
Increased
50
256.8M$224.5M1.5%———
Decreased
0
242.8M$224.4M1.5%———
Increased
51
215.9M$217.2M1.5%———
Decreased
0
??ASCENDIS PHARMA ADelisted
Bond
169.2M$201.1M1.4%———
Unchanged
0
173.7M$198.9M1.3%———
Increased
49
??FIVE9 INC
Bond
225.7M$192.8M1.3%———
New
70
175.9M$189.1M1.3%———
Increased
53
178.8M$186.6M1.3%———
New
70
120M$166.9M1.1%———
Increased
77
$14.7B
AUM
307
Positions
Q1 2025
Filing
Rating · 2.0
Quarterly Portfolio Change
-0%Q1'23$9.5B+0%Q2'23$9.5B+2%Q3'23$9.7B+8%Q4'23$10.5B+15%Q4'24$12.1B+22%Q1'25$14.7B
Activity profile
$ moved · Q1'25
New47%Increased23%Decreased9%Exited21%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.4 years
<1Q29%1-4Q21%1-2Y15%2Y+35%

LINDEN ADVISORS LP manages $14.7B across 307 positions as of Q1 2025. Top holdings: MICROSTRATEGY INC (3.7%), WESTERN DIGITAL CORP (3.3%), SUPER MICRO COMPUTER INC (2.6%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q1 2025 Summary

Active quarter - 93 new positions, 50 exits, 72 increased. No standout high-conviction moves this quarter. Portfolio: $14.7B across 307 positions.

Portfolio Allocation

Top holdings by portfolio weight

Total AUM$15B
MICROSTRATEG3.70%
WESTERN DIGI3.33%
SUPER MICRO 2.58%
COINBASE GLO2.13%
PG&#x26;E CO2.06%
LI AUTO INC2.04%
CONFLUENT IN1.99%
INSMED INC1.89%
LIBERTY MEDI1.86%
UNITED STATE1.67%
Other1.61%
Sector Breakdown

Portfolio allocation by GICS sector

Sectors6
Financial Services55.81%
Unknown24.82%
Technology14.07%
Utilities4.61%
Consumer Cyclical0.34%
Basic Materials0.34%
Fund DNA

Behavioral investing profile

Checking access…
Momentum Trader
Compare DNA across all funds
Fund Rating
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record61
Conviction31
Concentration37
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

HBK INVESTMENTS L PHBK INVESTMENTS L P
$8.5B
PICTON MAHONEY ASSET MANAGEMENTPICTON MAHONEY ASSET MANAGEMENT
$10.8B
Checking access…

Explore More

Compare LINDEN ADVISORS LP
Side-by-side holdings comparison
High-Conviction Picks
Top conviction positions this quarter
Double-Down Detection
Buying into price weakness
Best Trades
Top performing positions by P&L
All Momentum Trader Funds
Investing archetypes and behavior

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
BR10806XAD4BRIDGEBIO PHARMA INC
Q3 2024 → Q2 2026+157.4M shares+$200.5M
7Q
VI928298AR9VISHAY INTERTECHNOLOGY INC
Q4 2024 → Q2 2026+353.9M shares+$770.5M
4Q
CO19459JAC8COLLEGIUM PHARMACEUTICAL INC
Q3 2025 → Q2 2026+26.6M shares+$50.6M
Checking access…

Continue exploring

Explore high-conviction positions
See which stocks have the strongest institutional commitment
Compare with similar funds
Find portfolio overlap with LINDEN ADVISORS LP
Clone this fund
Backtest what copying LINDEN ADVISORS LP's portfolio would return

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used